Objective: To investigate if Cath-D, P-gp and Her-2 are correlated with prognosis in patients with cardiac carcinoma.
Methods: Histological sections of 43 patients with cardiac cancer were tested by immunohistochemistry and analyzed for pathological type and lymphatic metastasis.
Results: The research show and that P-gp and Her-2 were not significant in predicting lymphatic metastasis (P > 0.05), but Cath-D positive was significant in lymphatic metastasis (P < 0.01). The P-gp and Cath-D were not significant in differential level of cardiac carcinoma and expression of Her-2 was significant (P < 0.05).
Conclusion: The results suggest that positive Cath-D is correlated with metastases and positive Her-2 indicates poor survival. Special treatment plans for patients with carcinoma of the cardia should be designed depending on the above marker tests.